Lactose inhibits regulatory T-cell-mediated suppression of effector T-cell interferon-γ and IL-17 production

British Journal of Nutrition

Volumn 112, Issue 11, 2014, Pages 1819-1825

  Paasela, Monika ^a   Kolho, Kaija Leena ^b   Vaarala, Outi ^a   Honkanen, Jarno ^a  

^a NATIONAL PUBLIC HEALTH INSTITUTE   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Immunomodulation; Inflammation; Lactose; T cells

Indexed keywords

CD4 ANTIGEN; ECALECTIN; GAMMA INTERFERON; INTERLEUKIN 17; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 7 RECEPTOR; LACTOSE; MESSENGER RNA; CARBOHYDRATE DIET; GALECTIN; IMMUNOLOGIC FACTOR; LGALS9 PROTEIN, HUMAN;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; EFFECTOR CELL; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; IMMUNOREGULATION; IMMUNOSTIMULATION; PERIPHERAL BLOOD MONONUCLEAR CELL; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TH1 CELL; TH17 CELL; BIOSYNTHESIS; CARBOHYDRATE DIET; DRUG EFFECTS; GENE EXPRESSION; GENETICS; IMMUNOLOGY; PHARMACOLOGY;

ERAGROSTIS TEF;

ADULT; DIETARY CARBOHYDRATES; GALECTINS; GENE EXPRESSION; HUMANS; IMMUNOLOGIC FACTORS; INTERFERON-GAMMA; INTERLEUKIN-17; LACTOSE; T-LYMPHOCYTES, REGULATORY; TH1 CELLS; TH17 CELLS;

EID: 84925581176     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114514001998     Document Type: Article

References (43)

1. Francavilla R, Calasso M, Calace L, et al. (2012) Effect of lactose on gut microbiota and metabolome of infants with cow's milk allergy. Pediatr Allergy Immunol 23, 420-427.
2. Rasinpera H, Kuokkanen M, Kolho KL, et al. (2005) Transcriptional downregulation of the lactase (LCT) gene during childhood. Gut 54, 1660-1661.
3. Sahi T (1994) Hypolactasia and lactase persistence. Historical review and the terminology. Scand J Gastroenterol Suppl 202, 1-6.
4. Enattah NS, Sahi T, Savilahti E, et al. (2002) Identification of a variant associated with adult-type hypolactasia. Nat Genet 30, 233-237.
5. Tureci O, Schmitt H, Fadle N, et al. (1997) Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem 272, 6416-6422.
6. Wada J & Kanwar YS (1997) Identification and characterization of galectin-9, a novel β-galactoside-binding mammalian lectin. J Biol Chem 272, 6078-6086.
7. Chen X, Song CH, Liu ZQ, et al. (2011) Intestinal epithelial cells express galectin-9 in patients with food allergy that plays a critical role in sustaining allergic status in mouse intestine. Allergy 66, 1038-1046.
8. Jayaraman P, Sada-Ovalle I, Beladi S, et al. (2010) Tim3 binding to galectin-9 stimulates antimicrobial immunity. J Exp Med 207, 2343-2354.
9. Matsumoto R, Matsumoto H, Seki M, et al. (1998) Human ecalectin, a variant of human galectin-9, is a novel eosinophil chemoattractant produced by T lymphocytes. J Biol Chem 273, 16976-16984.
10. Hirashima M, Kashio Y, Nishi N, et al. (2004) Galectin-9 in physiological and pathological conditions. Glycoconj J 19, 593-600.
11. Kashio Y, Nakamura K, Abedin MJ, et al. (2003) Galectin-9 induces apoptosis through the calcium-calpain-caspase-1 pathway. J Immunol 170, 3631-3636.
12. Niki T, Tsutsui S, Hirose S, et al. (2009) Galectin-9 is a high affinity IgE-binding lectin with anti-allergic effect by blocking IgE-antigen complex formation. J Biol Chem 284, 32344-32352.
13. Seki M, Oomizu S, Sakata KM, et al. (2008) Galectin-9 suppresses the generation of Th17, promotes the induction of regulatory T cells, and regulates experimental autoimmune arthritis. Clin Immunol 127, 78-88.
14. Bi S, Hong PW, Lee B, et al. (2011) Galectin-9 binding to cell surface protein disulfide isomerase regulates the redox environment to enhance T-cell migration and HIV entry. Proc Natl Acad Sci U S A 108, 10650-10655.
15. Zhu C, Anderson AC, Schubart A, et al. (2005) The Tim-3 ligand galectin-9 negatively regulates T helper type 1 immunity. Nat Immunol 6, 1245-1252.
16. Sehrawat S, Reddy PB, Rajasagi N, et al. (2010) Galectin-9/TIM-3 interaction regulates virus-specific primary and memory CD8 T cell response. PLoS Pathog 6, e1000882.
17. +T cells and regulates Th1 and Th17 cytokines. Eur J Immunol 39, 2492-2501.
18. Chabot S, Kashio Y, Seki M, et al. (2002) Regulation of galectin-9 expression and release in Jurkat T cell line cells. Glycobiology 12, 111-118.
19. Oomizu S, Arikawa T, Niki T, et al. (2012) Galectin-9 suppresses Th17 cell development in an IL-2-dependent but Tim-3-independent manner. Clin Immunol 143, 51-58.
20. Damsker JM, Hansen AM & Caspi RR (2010) Th1 and Th17 cells: adversaries and collaborators. Ann N Y Acad Sci 1183, 211-221.
21. + regulatory T cells in immunological tolerance to self and non-self. Nat Immunol 6, 345-352.
22. Sakaguchi S, Sakaguchi N, Asano M, et al. (1995) Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor a-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 155, 1151-1164.
23. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 3, 135-142.
24. +T cell subsets that are differentially depleted during HIV infection. J Immunol 180, 5582-5592.
25. Seddiki N, Santner-Nanan B, Martinson J, et al. (2006) Expression of interleukin (IL)-2 and IL-7 receptors discriminates between human regulatory and activated T cells. J Exp Med 203, 1693-1700.
26. reg cell suppression. Nat Med 17, 989-995.
27. reg development by galectin-9 secretion. PLOS ONE 7, e48574.
28. Hosea Blewett HJ, Cicalo MC, Holland CD, et al. (2008) The immunological components of human milk. Adv Food Nutr Res 54, 45-80.
29. Wagner CL, Taylor SN & Johnson D (2008) Host factors in amniotic fluid and breast milk that contribute to gut maturation. Clin Rev Allergy Immunol 34, 191-204.
30. Adkins B, Leclerc C & Marshall-Clarke S (2004) Neonatal adaptive immunity comes of age. Nat Rev Immunol 4, 553-564.
31. Stockinger S, Hornef MW & Chassin C (2011) Establishment of intestinal homeostasis during the neonatal period. Cell Mol Life Sci 68, 3699-3712.
32. Cederlund A, Kai-Larsen Y, Printz G, et al. (2013) Lactose in human breast milk an inducer of innate immunity with implications for a role in intestinal homeostasis. PLOS ONE 8, e53876.
33. Mishra A & Makharia GK (2012) Techniques of functional and motility test: how to perform and interpret intestinal permeability. J Neurogastroenterol Motil 18, 443-447.
34. + cells through TLR4. Proc Natl Acad Sci U S A 110, 17444-17449.
35. Mohan C (2006) Environment versus genetics in autoimmunity: a geneticist's perspective. Lupus 15, 791-793.
36. Smyk D, Rigopoulou EI, Baum H, et al. (2012) Autoimmunity and environment: am I at risk? Clin Rev Allergy Immunol 42, 199-212.
37. Weaver CT, Elson CO, Fouser LA, et al. (2013) The Th17 pathway and inflammatory diseases of the intestines, lungs, and skin. Annu Rev Pathol 8, 477-512.
38. Ramsay DB, Stephen S, Borum M, et al. (2010) Mast cells in gastrointestinal disease. Gastroenterol Hepatol (N Y) 6, 772-777.
39. Flatz G & Rotthauwe HW (1977) The human lactase polymorphism: physiology and genetics of lactose absorption and malabsorption. Prog Med Genet 2, 205-249.
40. Smith GD, Lawlor DA, Timpson NJ, et al. (2009) Lactase persistence-related genetic variant: population substructure and health outcomes. Eur J Hum Genet 17, 357-367.
41. Compston A & Coles A (2008) Multiple sclerosis. Lancet 372, 1502-1517.
42. Maahs DM, West NA, Lawrence JM, et al. (2010) Epidemiology of type 1 diabetes. Endocrinol Metab Clin North Am 39, 481-497.
43. Molodecky NA, Soon IS, Rabi DM, et al. (2012) Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. Gastroenterology 142, 46-54.